Vassiliki Grigoraki

Pure infradiaphragmatic Hodgkin's lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic disease.

N. Konstantinou, M. Angelopoulou, G. Pangalis, 2006, Haematologica.

Treatment of Waldenstrom's macroglobulinemia with thalidomide.

M. Dimopoulos, N. Viniou, P. Panayiotidis, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thalidomide and dexamethasone combination for refractory multiple myeloma.

M. Dimopoulos, K. Zervas, C. Papadimitriou, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.

M. Dimopoulos, M. Kyrtsonis, E. Terpos, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of Waldenström's macroglobulinemia with rituximab.

M. Dimopoulos, D. Gika, N. Viniou, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F‐negative polycythaemia vera patients

W. Vainchenker, P. Fenaux, L. Scott, 2008, British journal of haematology.

Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma.

M. Dimopoulos, E. Efstathiou, D. Gika, 2004, The hematology journal : the official journal of the European Haematology Association.

Treatment of Waldenstrom's Macroglobulinemia with the Combination of Fludarabine and Cyclophosphamide

M. Dimopoulos, C. Papadimitriou, E. Efstathiou, 2003, Leukemia & lymphoma.

Multiple myeloma in elderly patients: prognostic factors and outcome

M. Dimopoulos, K. Zervas, D. Gika, 2005, European journal of haematology.